The excitatory neurotransmitter glutamate is removed from the synaptic cleft by several related sodiumand potassium-coupled transporters. They thereby restrict the neurotoxicity of this transmitter. Based on the accessibility of single cysteines to the large sulfhydryl reagent 3-N-maleimidyl(propionyl)biocytin, we have proposed a topological model for the astroglial glutamate transporter GLT-1 (Grunewald, M., Bendahan, A. and Kanner, B. I. (1998) Neuron 21, 623-632). Because of several unexpected observations, we have investigated the topological disposition of 19 cysteine residues engineered into a loop proposed to be intracellular. We have probed the accessibility of these cysteines to small and large sulfhydryl reagents. The impermeant hydrophilic sulfhydryl reagent [(2-trimethylammonium)ethyl] methanethiosulfonate inhibits transport activity only at two of these positions, weakly at G365C and potently at A364C. Glutamate and its nontransportable analogue dihydrokainate markedly protect A364C transporters against this impermeant reagent. Using a biotinylated maleimide, we found that, among the 14 mutants tested with it, only A364C is accessible to it from the extracellular side. This, together with our previous observations, indicates that the loop-including amino acid residues 354, 359, 373, and 379 -is largely intracellular, but a short region of it forms a reentrant pore-loop-like structure, the accessibility of which is dependent on the conformation of the transporter.
The excitatory neurotransmitter glutamate is removed from the synaptic cleft by several related sodiumand potassium-coupled transporters. They thereby restrict the neurotoxicity of this transmitter. Based on the accessibility of single cysteines to the large sulfhydryl reagent 3-N-maleimidyl(propionyl)biocytin, we have proposed a topological model for the astroglial glutamate transporter GLT-1 (Grunewald, M., Bendahan, A. and Kanner, B. I. (1998) Neuron 21, 623-632). Because of several unexpected observations, we have investigated the topological disposition of 19 cysteine residues engineered into a loop proposed to be intracellular. We have probed the accessibility of these cysteines to small and large sulfhydryl reagents. The impermeant hydrophilic sulfhydryl reagent [(2-trimethylammonium)ethyl] methanethiosulfonate inhibits transport activity only at two of these positions, weakly at G365C and potently at A364C. Glutamate and its nontransportable analogue dihydrokainate markedly protect A364C transporters against this impermeant reagent. Using a biotinylated maleimide, we found that, among the 14 mutants tested with it, only A364C is accessible to it from the extracellular side. This, together with our previous observations, indicates that the loop-including amino acid residues 354, 359, 373, and 379 -is largely intracellular, but a short region of it forms a reentrant pore-loop-like structure, the accessibility of which is dependent on the conformation of the transporter.
Electrogenic (Na ϩ ϩ K ϩ )-coupled glutamate transporters, located in the plasma membranes of nerve terminals and glial cells, fulfill an important role in the process of excitatory transmission. They keep the extracellular level of the transmitter below neurotoxic levels (1) (2) (3) (4) . Moreover, at some synapses, glutamate transporters appear to be important in limiting the duration of synaptic excitation (5) (6) (7) (8) . They achieve this by an electrogenic process (9 -11) in which the transmitter is cotransported with three sodium ions and one proton (12) , followed by countertransport of a potassium ion (12) (13) (14) (15) . It appears that the three sodium ions are not equivalent. Two of them are probably not entirely specific and can be replaced by lithium, but one is completely specific (16) .
The astroglial glutamate transporter GLT-1 has been purified from rat brain to near homogeneity and reconstituted (17, 18) . It has been cloned (19) and is related (around 50% sequence identity) to three different glutamate transporters from the central nervous system (20 -22) , as well as to one from the retina (23) . The physiological importance of GLT-1 for brain function has been illustrated by knockout experiments (3, 4) .
A large hydrophobic region (residues 340 -490, GLT-1 numbering) is highly conserved not only in the five glutamate transporters but also in small neutral amino acid transporters (24 -27) as well as in bacterial glutamate and dicarboxylic acid transporters (28) . It contains several amino acid residues that play a key role in glutamate transport (15, 29 -31) . Its topology has been enigmatic for a long time (19 -21) . Initial attempts to determine this topology experimentally revealed strikingly different topologies for this important large hydrophobic region (32, 33) . This is probably because in both studies, inactive truncated constructs fused to reporter groups were employed. Some of the fusion proteins are likely folded in a nonnative conformation.
Recently, we have determined the topology of GLT-1, based on the accessibility of functional single cysteine-containing GLT-1 transporters to the biotinylated sulfhydryl reagent 3-Nmaleimidyl(propionyl)biocytin (BM) 1 (34) . We reported that the large highly conserved hydrophobic domain consists of a long intracellular loop, followed by two TMs, TM7 and TM8, which are long enough to span the membrane as ␣-helices. Between TM7 and TM8, we identified a pore-loop-like structure followed by a hydrophobic linker with many residues accessible from the outside (34) . TM7 contains two residues implied in the binding and/or translocation of potassium (15, 29, 30) and another stretch of five amino acid residues, which are possibly involved in the binding of one of the sodium ions (29, 30) . The pore-looplike structure of GLT-1 contains a serine residue, located close to the glutamate binding site and important for sodium selectivity (31) .
One of the next steps in the study of the structural basis of transporter function is to establish proximity relationships between the TMs. One approach is to create, under oxidative conditions, a disulfide bond between two single cysteines each located at a different TM or loop (35) . Such cross-links could be easily detected if the two cysteines are located on different parts of a split transporter (35, 36) . We decided to perform the split of GLT-1 in the long intracellular loop at position 373. Even though the two parts were expressed, as judged by immunoprecipitation with antibodies raised against epitopes from amino and carboxyl termini, respectively (16), the activity was not restored upon coexpression (data not shown). This would not be expected if the loop was completely intracellular and not interacting with the TMs. Moreover, based on studies with the small impermeant MTSET (37, 38) it was reported that residue 395 of the glutamate transporter EAAT-1 (equivalent to residue 393 of GLT-1) is located extracellularly (39) , rather than at the end of the large intracellular loop (34) . Therefore, we decided to reexamine the topological disposition of this loop using both small and large sulfhydryl reagents. It appears that most of the loop is intracellular, but at least one residue is accessible from the outside by both types of sulfhydryl reagents. Its accessibility is restricted in the presence of glutamate and its analogues.
EXPERIMENTAL PROCEDURES
Cell Growth and Expression-HeLa cells were cultured (40) , infected with recombinant vaccinia/T7 virus vTF (41) , and transfected with plasmid DNA encoding wild-type, cysteine-less, or mutant GLT-1, as described (40) . Transport measurements were done as described (42) (30) . Briefly, cells were plated in 24-well plates and washed with a medium consisting of 150 mM choline chloride/0.5 mM MgSO 4 /0.3 mM CaCl 2 /5 mM KPi, pH 7.4. The cells were then incubated at room temperature with 200 l of either the above medium or one containing NaCl instead of choline chloride. Other additions are indicated in the legends to Figs. 2, 4, and 5. After 5 min, the medium was aspirated, and the cells were washed twice with 1 ml of the choline chloride-containing medium, followed by the transport assay, using 200 l of NaCl-containing transport medium supplemented with 0.4 Ci of the radiolabeled amino acid for each well. Each experiment was performed at least three times.
Site-directed Mutagenesis-Site-directed mutagenesis (42, 43) was done by using uracil-containing single-strand DNA derived from the His-tagged cysteine-less GLT-1 construct (30, 34) . After verification of the mutants by testing for the presence of the restriction site engineered together with the mutation, the mutants were subcloned into the original constructs using BsrGI and BstEII. Subcloned DNAs were sequenced in both directions between these two unique restriction sites. In the case of G365C, subcloning was done with AvrII and BstEII. Mutants T360C and S362C were not subcloned. The insert of S362C was sequenced throughout the entire length of the coding region in both directions. In the case of T360C, two independent mutants were tested for transport, with identical results.
Labeling of Single Cysteine Transporters with BM and Purification on Nickel-Nitrilotriacetic Acid
Beads-This was done exactly as described (34) . To the eluates from the nickel-nitrilotriacetic acid beads was added 6-fold concentrated SDS-PAGE sample buffer containing 2-mercaptoethanol (18%). After SDS-PAGE, they were transferred onto nitrocellulose, and the biotinylated proteins were detected by using streptavidin-peroxidase and enhanced chemiluminescence (ECL) (Amersham Pharmacia Biotech) according to the instructions of the manufacturer. For each of the mutants, determination of accessibility to BM was performed at least three times.
Cell Surface Biotinylation-HeLa cells expressing the transporters were surface biotinylated with sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate, and the biotinylated proteins were recovered and processed as described (44) .
RESULTS

Cysteine Scanning Accessibility of Residues 347-393-Using
the cysteine-less GLT-1 (CL-H) with a deca-histidine tail at its carboxyl terminus (30, 34) as a parent construct, we have replaced 19 residues of the long loop connecting TM6 with TM7 one at a time by cysteine. After transient expression of the CL-H construct and the cysteine replacement mutants in HeLa cells, transport of D-[ 3 H]aspartate was monitored. Very little transport (1-10% of CL-H activity) was detected when cysteine was introduced in each of the four consecutive residues from 360 -363, and the same was true at positions 357 and 384. In three other mutants-G365C, T370C, and G392C-the activity was somewhat higher (15-25% of CL-H) (Fig. 1) . Cysteine replacement at the other 10 positions left significant biological activity, 45-95% of the cysteine-less transporter. Transport activity of CL-H and most of these active mutants, including A393C, was not significantly inhibited by 1 mM of the small impermeant sulfhydryl reagent MTSET (Fig. 2) . Similar results were also obtained when sodium was replaced by choline during the preincubation period with the sulfhydryl reagent (data not shown). Only in two cases did MTSET cause a significant inhibition of D-[ 3 H]aspartate transport, namely in A364C and G365C mutants (Fig. 2) . The sensitivity of A364C to MTSET is far greater than that of G365C; MTSET at 30 M inhibited A364C to the same extent as when it is used at 1 mM (see also Fig. 4 ), whereas at 100 M, the inhibition of G365C was only 20% (data not shown).
Biotinylation of Active Single Cysteine Transporters-The accessibility of single cysteines of some of the active mutants by the large sulfhydryl reagent BM is illustrated in Fig. 3A . HeLa cells expressing the GLT-1 mutant constructs were reacted with BM. After solubilization of the membrane proteins, the histidine-tagged transporters were purified on nickel-nitrilotriacetic acid beads. The covalently bound biotin is readily visualized after SDS-PAGE by probing the blotted proteins with streptavidin-peroxidase. The biotinylated His-tagged wild-type transporter, which contains nine endogenous cysteines, runs as a broad band centered around 64 kDa (Fig. 3A, lower arrow) . It represents an immature form residing in internal membranes that is labeled by BM from the cytoplasmic side (Ref. 34 and see below). The appearance of this band is not suppressed by preincubation with the membrane impermeant MTSET (34) . The A364C transporters run as a broad band centered around 72-74 kDa (Fig. 3A, upper arrow) , just as described for the mature plasma membrane form of the transporter (34) . It has a lower mobility than the monomeric wild-type transporter (Fig. 3A, lower arrow) . Further evidence for the assignment of plasma membrane and intracellular forms of the transporter is provided by cell surface biotinylation experiments employing the impermeant sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate (44) , which reacts with external lysine residues (Fig. 3B) . Thus, only those transporters accessible from the extracellular medium are biotinylated with this reagent. They were purified using streptavidin-agarose beads. Upon Western blotting with a specific antibody, a broad band centered around 72-74 kDa (Fig. 3B, upper arrow) was detected, and this represents the mature form of the transporter located in the plasma membrane. It represents only a small fraction of the total transporter pool-most of it is not accessible from the outside. The majority of this pool runs as a 62-64-kDa band (Fig. 3B, lower arrow) . This immature form of the transporter is apparently residing in intracellular membranes. Interestingly, in the experiment depicted in Fig. 3A , a band corresponding to the immature form of A364C was observed, in addition to the plasma membrane form (Fig. 3A) . Preincubation of the cells expressing A364C transporters with the membrane impermeant sulfhydryl reagent MTSET (37, 38) blocks the biotinylation of the plasma membrane form, but not that of the immature transporter (Fig. 3A) . Thus, the plasma membrane form of the A364C transporters can be biotinylated from the extracellular side. Neither of these two bands was observed in the cysteine-less transporter (Fig. 3A) . In this case, only a number of nonspecific bands lit up; these bands were also observed in HeLa cells expressing the vector pBluescript SK Ϫ alone (data not shown). The plasma membrane form of the other active single cysteine transporters was not biotinylated, as exemplified by G365C and A393C (Fig. 3A) . Thus, the stretch surrounding alanine 364 behaves as a reentrant loop, with its apex facing the extracellular medium.
Altered Accessibility of Alanine 364 in the Presence of Substrate-At four positions adjacent to alanine 364, 360 -363, replacement by cysteine leads to transporters with very low activity (1-10% of CL-H) (Fig. 1) . This indicates that this reentrant loop may fulfill an important role in the transport process. Because it is well known that conformational changes accompany glutamate transport (16, 30) , we have investigated the accessibility of A364C transporters to MTSET in the presence and absence of substrates (Fig. 4) . Preincubation of HeLa cells expressing A364C for 5 min with 30 M MTSET leads to inhibition of more than 80% of D-[ 3 H]aspartate transport. Strikingly, when substrates such as L-glutamate or D-aspartate were added to the preincubation medium, a marked protection against the inhibition by the sulfhydryl reagent was observed (Fig. 4A) . The specificity of this effect is illustrated by the fact that ␥-aminobutyric acid, which does not interact with GLT-1 (19), did not afford any protection. The competitive inhibitor DHK, a nontransportable glutamate analogue, also protected, but to a lower extent (Fig. 4A) . Importantly, in order for Lglutamate to exert its effect, its cosubstrate sodium has also to be present during the preincubation. When it was replaced by choline, no protection by glutamate was observed, and the same was true for DHK (Fig. 4B) . -1,3 -dithiopropionate, the cells were lysed, and the biotinylated proteins were recovered with streptavidin-agarose beads. For the total proteins, a sample of the lysate, equivalent to 7.5% of the cells used for the biotinylated sample, was subjected directly to SDS-PAGE. The transporters were detected with an affinity-purified antibody against an epitope located in the carboxyl terminus of GLT-1 (P-694 (16)) followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG and ECL. tion of A393C by the nonpermeant MTSET (Fig. 2) is of particular interest, because it has been reported that in a sodiumcontaining medium, the analogous single cysteine mutant A395C of EAAT-1 is inhibited by it in a glutamate-protectable fashion (39) . Although not so likely, one possibility to explain this difference between the two transporters is that, in contrast to EAAT-1, modification at this position in the context of GLT-1 is without functional consequences. MTSET does not inhibit A393C-GLT-1 transporters in either a sodium-containing medium or a choline-containing medium (Fig. 5) . However, preincubation of A393C-GLT-1 transporters with the permeant MTSEA leads to a significant inhibition, which is potentiated in the absence of sodium (Fig. 5) . Clearly, the lack of inhibition of A393C by MTSET is not due to the absence of functional consequences of the insertion of a positive group at position 393.
Effects of MTS Reagents on
DISCUSSION
The major new finding reported in this paper is that the glutamate transporter GLT-1 has a new reentrant loop in addition to the one reported previously by us (34) . Position 364, located on a largely intracellular loop (34) , is accessible to BM from the outside (Fig. 3A) . Thus, it is part of a reentrant loop (Fig. 6) . It resides in a conserved serine-rich stretch, which appears important for the function of the transporter. Replacement of residues 360 -363-all of which are conservative-by cysteine results in greatly impaired transport activity (Fig. 1) . Furthermore, modification of the cysteine inserted at position 364 by the impermeant sulfhydryl reagent MTSET also results in the loss of function (Fig. 2) . It is possible that also one or more of the residues 360 -363 are accessible from the outside, but because the transporters with cysteines in this position are inactive, it is impossible to determine this with the available methodology. Interestingly, in addition to the MTSET sensitive plasma membrane form of A364C, a faster moving band, resistant to inhibition by MTSET is detected (Fig. 3A) . The mobility of this resistant form is similar to that of the immature form residing in intracellular organelles (Ref. 34 and Fig. 3B ). Thus, BM, which is capable of crossing the plasma membrane (34, 45) , can label the internal inside-out form of A364C. Thus, it is likely that the access channel through the transporter is rather wide from the inside, enabling BM to approach residue 364 from that side. It is of interest to note that this faster moving form is not detected in V417C transporters (34) . In the internal inside-out form, a cysteine in position 417 cannot be approached from the cytoplasm. For the internal transporter to be labeled, BM would have to cross two membranes. This apparently happens at a negligible rate. Thus, valine 417 is located more extracellularly than alanine 364, and this is indicated in Fig. 6 .
Recently, it was reported that in the related EAAT-1 transporter, there is yet another reentrant loop (39) . The activity of mutants with cysteines introduced in positions corresponding to residues 393 and 412 of GLT-1 was sensitive to MTSET. An external location of 412 is in full agreement with our own assignment (34) , but in GLT-1, A393C transporters are not sensitive to the impermeant MTSET but only to permeant MTSEA, especially in the absence of sodium (Fig. 5) . Because MTSET is a small molecule, a likely explanation is that in EAAT-1, it can move to a large part of the translocation pathway and react with A393C, located close to the intracellular side of the membrane. On the other hand, this penetration is not possible in GLT-1, perhaps because one or more of the side chains of the amino acid residues lining the permeation pathway are bulkier than their counterparts in EAAT-1. Not only do we not have any evidence for accessibility of A393C to MTSET, it is also not accessible to BM (Fig. 3A) , and thus we conclude that this position is internal, at least in GLT-1. This is in line with all the evidence we obtained previously (34) , and thus the stretch connecting positions 393 and 412 forms a transmembrane domain long enough to span the membrane as an ␣-helix (Ref. 34 and Fig. 6 ).
Thus, it appears that GLT-1 has two reentrant loops; the one discovered previously (Fig. 6, loop II) comes from the outside, goes in, and moves out again (34) . The reentrant loop identified here has the reverse orientation (Fig. 6, loop I ). There are some similarities between these two loops: 1) substrates and the nontransportable glutamate analogue DHK protect against the modification of key residues in both loops, A364C (Fig. 4) and S440C (31) . 2) Both loops contain critical residues. Serine 440 is close to the glutamate binding site and is important for ion selectivity (31) , whereas positions 360 -363 do not tolerate a conservative replacement by cysteine. It will be of considerable interest to find out in which steps of the translocation cycle they participate. One way to approach this would be to replace those residues by other amino acids, followed by a detailed biochemical and electrophysiological analysis.
The presence of reentrant loops is not well documented in transporters but is well established in ion channels (46) . The pore-loop of voltage dependent ion channels is a stretch of residues that influences single channel current selectivity among ions and open channel blockade (47-49). The structure of a related potassium channel containing a pore-loop was recently solved (50) . This pore-loop was shown to span only a small part of the width of the membrane. A region critical for the ion selectivity of glutamate receptors also appears to be folded as a pore-loop (51) . Even though no significant homology between the reentrant loops of GLT-1 and the pore-loops of ion channels can be detected, it is possible that the loops of GLT-1 are folded in a similar way. It is of interest to note that the substrate protection in A364C, as well as in S440C, is different from that observed in Y403C (40) . In the latter case, the effects of glutamate and DHK on MTSET inhibition are opposite and are compatible with alternating access of this residue (30) Either A364C is directly protected by glutamate and DHK or the effect is an indirect long range conformational change. If the protection is direct, position 364 is close to the substrate binding site, but deeper in the translocation pathway. In this scenario, it might be that positions 364 and 440, residing on different reentrant loops, are close in space. An important future approach will be therefore to determine this proximity relationship and that of other pairs.
While this article was in preparation, an article was published documenting the presence of a glutamate sensitive reentrant loop, similar to the one reported here, in a bacterial homologue of GLT-1 (52) .
